June 20 (Reuters) – Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).
($1 = 94.3200 Indian rupees)
(Reporting by Devika Nair in Bengaluru; Editing by Alexandra Hudson)
